๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Colitis, Ulcerative
Clinical trial register · Japan

Colitis, Ulcerative Trials in Japan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2472 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:48 UTC
2472
Studies in scope
all four open statuses
1255
Recruiting now
open to new participants
347
Lead sponsors
across recruiting studies
Top sites
Hamamatsu 5 Kashiwa 5 Yokohama 4 Kumamoto 4 Bunkyล City 3
Narrow the registerReset
Recruitment status
Phase
Site location
Hamamatsu5 Kashiwa5 Yokohama4 Kumamoto4 Bunkyล City3
All 67 locations
Target enrolment
to

Colitis, Ulcerative trials in Japan

14 of 2472 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
NCT07470879Colitis, Ulcerative
Pfizer
Phase 2
24
Saitama-shi, Kumamoto, Tokyo
2026-05-28
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
644
Hamamatsu, Higashi-Ibaraki, Kagoshima, Kashiwa, Kumamoto, Minatoku, Nagakute, Osaka
2026-05-23
Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
NCT07196748Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
882
Chiba, Chลซลku, Fujiidera-shi, Fukui-shi, Fukuoka, Gamagลri, Hamamatsu, Higashiibaraki-gun
2025-10-01
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Kashiwa, Sakura, Chikushino-shi, Maebashi, Shiwa-gun, Yokohama, Tsu, Sendai
2025-05-27
Active, closed
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
NCT06867094Colitis Ulcerative
Sanofi
Phase 2
204
Kashiwa, Kure, Sapporo, Yahaba, Yokohama, Bunkyo-Ku, Kodaira, Kofu
2025-03-28
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Fuchลซ, Kanazawa, Kobe, Kumamoto, Matsumoto, Saga, Yokohama
2024-10-29
Active, closed
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
NCT06260163Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
112
Fuchลซ, Kanazawa, Kobe, Kumamoto, Matsumoto, Saga, Setagaya Ku, Shinjuku
2024-01-19
Active, closed
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
NCT05668013Crohn Disease, Colitis, Ulcerative
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
247
Kashiwa, Minato, Sakura, Shinjuku, Toyama
2023-01-11
Active, closed
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
NCT05588843Colitis Ulcerative
Sanofi
Phase 2
187
Nagaoka, Hamamatsu, Chลซล, Fukushima, Osaka, ลŒita, Saitama
2022-11-25
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05242484Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 2
577
Asahikawa, Bunkyล City, Chikushino-shi, Fukuoka-ken, Gifu, Hachiลji, Hamamatsu, Hirosaki
2022-09-19
Active, closed
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05528510Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
418
Bunkyล City, Chลซลku, Fujiidera-shi, Fukuoka, Fukushima, Hachinohe, Hachiลji, Hamamatsu
2022-09-13
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
NCT05076175Colitis, Ulcerative
Bristol-Myers Squibb
Phase 2/3
120
ลŒbu, Kurume-shi, Komatsu, Yokohama, Takatsuki, Bunkyo-Ku, Setagaya-ku, Shinjuku-ku
2022-05-30
Active, closed
A Long-term Extension Study of Ustekinumab in Pediatric Participants
NCT05092269Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 3
159
Bunkyล City, Gunma, Ikoma, Kurume, Saitama Shi, Sendai, Setagaya Ku, Tsu
2021-10-18
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-japan/condition/colitis-ulcerative

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,472 studies in total at the last sync on 26 Sep 2026, 19:48 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Colitis, Ulcerative.

How many Colitis, Ulcerative trials are recruiting in Japan?

6 of the 14 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:48 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Colitis, Ulcerative), 14 studies
PhaseStudiesRecruitingShare
Phase 27250%
Phase 36342.9%
Phase 2/3117.1%

Most active sponsors

Lead sponsors with the most studies (Colitis, Ulcerative)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC73
Sanofi30
Bristol-Myers Squibb11
Pfizer11
Spyre Therapeutics, Inc.11
Teva Branded Pharmaceutical Products R&D LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.